NIH Locks Doors for April Grant Review Sessions
Published Date: 3/24/2026
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings on April 17, 2026, to review and evaluate important grant applications in health and science fields. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
NIH grant reviews on April 17 & 20
The NIH Center for Scientific Review will hold multiple closed virtual panels to review and evaluate grant applications on April 17, 2026 (panels with times listed between 9:00 a.m. and 7:00 p.m.) and April 20, 2026 (panels with times listed between 8:00 a.m. and 7:00 p.m.). If you are a researcher or organization that applied for these NIH grants, those applications will be reviewed on those dates and funding decisions may follow.
Confidential handling of grant materials
The meetings are closed to the public under 5 U.S.C. 552b(c)(4) and (c)(6) to protect confidential trade secrets, patentable material, and personal information in grant applications. This safeguards applicants’ proprietary and private information during the April 17 and April 20, 2026 review sessions.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06283 — Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration
The National Eye Institute plans to give Perpetual Biosciences, Inc. an exclusive license to use special PEDF peptides to treat eye diseases that cause vision loss. This means the company will have the sole right to develop and sell this promising treatment, potentially helping millions with retinal degeneration. If you want to comment or apply for a license, act fast—submissions close April 16, 2026!
2026-05957 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2026 to review and decide on important research grant applications. These meetings affect scientists seeking funding in areas like neuroscience, cancer, and liver disease. No public access is allowed to protect private info and trade secrets, and these reviews help decide where millions in research money will go.
2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.
2026-05738 — Submission for OMB Review; 30-Day Comment Request; National Institutes of Health (NIH) Loan Repayment Programs, (Office of the Director)
The NIH is asking for a 30-day public comment on extending its Loan Repayment Programs that help doctors and scientists pay off their student loans while they do important health research. This extension keeps the program running smoothly with no big changes, and comments are due by April 23, 2026. If you’re a researcher with student loans, this program could save you money while you help improve health!
2026-05527 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a cool new gene-editing invention that can fix a rare genetic disease called ROSAH syndrome, which causes vision loss and other problems. Companies can license this technology to develop treatments that might restore vision and improve lives. Interested parties should act soon and be ready to sign a confidentiality agreement to get all the details.
2026-05238 — Submission for OMB Review; 30-Day Comment Request Hazardous Waste Worker Training-42 CFR Part 65, National Institute of Environmental Health Sciences (NIEHS)
The National Institute of Environmental Health Sciences (NIEHS) is asking for public feedback on their plan to collect info from groups that train hazardous waste workers. This helps make sure the training programs are effective and safe. If you’re involved in hazardous waste training, your input matters before the review deadline on March 18, 2026, and there’s no new cost for participants.
Previous / Next Documents
Previous: 2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.
Next: 2026-05674 — Notice of Lodging of Proposed Consent Decree Under the Comprehensive Environmental Response, Compensation, and Liability Act
The government and ABB, Inc. are teaming up to clean up hazardous waste at the Henry's Knob Superfund Site in South Carolina. ABB will pay over $471,000 for past cleanup costs and cover future expenses while carrying out important cleanup work. The public has 30 days to share their thoughts on this plan before it’s finalized.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in